Last summer, the U.S. Food and Drug Administration (FDA) warned that using Actos for more than a year could significantly raise the risk of bladder cancer.
New York, NY (PRWEB) December 04, 2012
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of a Florida woman who alleges that the use of Actos caused bladder cancer and the subsequent death of her husband. The suit was filed on November 14th in the U.S. District Court for the Western District of Louisiana (Case 6:12-cv-02886-RFD-PJH). It is one of the many cases that have been filed into the multidistrict litigation known as In Re: Actos (Pioglitazone) Products Liability Litigation (MDL No. 6:11-md-2299). Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company have been named as Defendants.
According to the Complaint, the Plaintiff’s decedent started taking Actos in April 2011 and subsequently developed bladder cancer. The Plaintiff’s decedent died in May 2012, as an alleged result of having taken the diabetes drug. The lawsuit is seeking compensation for damages suffered by the Decedent, including extensive pain and suffering, severe emotional distress and the substantially reduced ability to enjoy life. The suit alleges that the injuries and damages suffered by the Plaintiff’s decedent are a direct result of using Actos. The lawsuit alleges that the Defendants knew Actos could cause bladder cancer but did not warn consumers or the public.
Last summer, the U.S. Food and Drug Administration (FDA) warned that using Actos for more than a year could significantly raise the risk of bladder cancer. The safety information on Actos was updated to include this warning, which was based on data from ongoing 10-year study by Kaiser Permanente.
Actos lost its patent in August, making way for generic versions of the drug. According to Consumer Reports, however, both generic and brand name Actos should only be used as a last resort for patients with Type 2 diabetes because there are several safer options available. That same month, the Journal of the National Cancer Institute confirmed that the long-term use of Actos and other similar medications was associated with an increased risk of bladder cancer. The month prior, a study in the Canadian Medical Association Journal found that patients taking Actos were 22 percent more likely to develop bladder cancer.
Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney